PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
Publication|Articles|December 2, 2023
- Pharmaceutical Technology, December 2023
- Volume 47
- Issue 12
- Pages: 23
Ribbon Blenders
Author(s)Pharmaceutical Technology Editors
ROSS’ Ribbon Blenders are designed to handle a wide range of dry materials and effectively coat individual solid particles, keeping long-term performance and quality in mind.
ROSS’ Ribbon Blenders are designed to handle a wide range of dry materials, from seasonings and beverage mixes to pharmaceuticals, chemicals, plastics, and agricultural powders or granules. These blenders also incorporate minor liquid components to effectively coat individual solid particles. They are manufactured with long-term performance and quality in mind.
The pictured ROSS Model 42N-18SS is crafted from type 316 stainless steel with interior surfaces polished to a 150-grit finish. With a maximum working capacity of 18 ft³, the blender is direct-driven by a 10-horsepower gearmotor for processing materials with a bulk density of up to 60 lbs/ft³.
The agitator is a solid double ribbon design, designed for center discharge, with internal flanges welded to shaft stub ends and a heavy-duty anti-friction bearing on the non-driven end. The blender includes a two-piece safety grating with half-inch diameter perforations for safe operation while the split folding covers are open. A spray bar with fan-type spray nozzles is installed on the trough via sanitary tri-clamp connections for liquid additions. The blender is operated from a four-inch color touchscreen that includes a cycle timer, start/stop, forward/reverse, and speed controls. The finished product is discharged through a pneumatically operated four-inch dust-tight knife gate valve.
Articles in this issue
almost 3 years ago
Training for Operational Excellencealmost 3 years ago
Revolutionizing Biomanufacturing: The Digitalization Advantagealmost 3 years ago
Establishing a Framework for Reliable Pharma Labelingalmost 3 years ago
Revitalizing Quality Management Processes through Digitalizationalmost 3 years ago
Falling ShortRelated to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.